Guardant Health
GH
#2480
Rank
โ‚น502.95 B
Marketcap
โ‚น4,071
Share price
-5.93%
Change (1 day)
123.84%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -โ‚น42.74 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น0.69 Billion. In 2023 the company made an earning of -โ‚น41.49 Billion, an increase over its 2022 earnings that were of -โ‚น56.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น42.74 Billion3.01%
2023 -โ‚น41.49 Billion-26.73%
2022 -โ‚น56.62 Billion69.96%
2021 -โ‚น33.32 Billion56.35%
2020 -โ‚น21.31 Billion252.69%
2019 -โ‚น6.05 Billion-17.22%
2018 -โ‚น7.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น18.41 Billion-58.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น2.74 Billion-93.84%๐Ÿ‡บ๐Ÿ‡ธ USA